-
Novo Nordisk: Simeglutide 2.4mg shows significant improvement in liver fibrosis symptoms and will submit regulatory approval to the United States and the European Union in the first half of 2025
Southern Finance and Economics, November 2nd - Novo Nordisk announced on its official website on Friday (November 1st) the results of the first phase of an ongoing Phase III trial, in which 2.4 milli ... -
Wenyuan Zhixing's new generation Robotaxi will be released on October 15th
Recently, the official public of the autonomous driving enterprise Wenyuan Zhixing claimed that on October 15, the new generation Robotaxi of Wenyuan Zhixing will be launched globally. In July 2024, ... -
AMD announces that it will hold a CES 2024 speech on January 8th to discuss the future of AI PCs
AMD announced that it will hold a CES 2024 speech on January 8th to discuss the future of AI PCs. AMD announced that it will hold a CES 2024 speech at 7am Pacific Time on January 8th. The official st ...